Abstract
Introduction/BackgroundAdvanced clear cell gynaecological cancers (CCGC) have poor prognosis with objective response rates (ORR) to second-line chemotherapy between 0–8%. Preliminary clinical activity with PD-1 inhibitors have been described in CCGC....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have